Source: National Health Investors, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026
Revenue, net income & free cash flow
Income statement
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$248.46M
$278.66M
$294.61M
$318.08M
$0
$0
$35.80M
$48.81M
$54.42M
$80.06M
Interest expense
$43.11M
$46.32M
$49.05M
$56.30M
$52.88M
$50.81M
$44.92M
$58.16M
$59.90M
$57.37M
Pre-tax income
$118.77M
$151.49M
$155.07M
$161.27M
—
—
—
—
—
—
Income tax
$854.00K
$124.00K
$138.00K
—
—
—
—
—
—
—
Net income
$151.54M
$159.37M
$154.33M
$160.46M
$185.13M
$111.80M
$66.40M
$135.65M
$137.99M
$142.18M
EPS (basic)
$3.88
$3.90
$3.68
$3.70
$4.14
$2.45
$1.48
$3.13
$3.14
$3.03
EPS (diluted)
$3.87
$3.87
$3.67
$3.67
$4.14
$2.44
$1.48
$3.13
$3.13
$3.02
Diluted shares
39.16M
41.15M
42.09M
43.70M
44.70M
45.73M
44.79M
43.39M
44.10M
47.05M
Net margin
61.0%
57.2%
52.4%
50.4%
—
—
185.5%
277.9%
253.6%
177.6%
Balance sheet
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash & equivalents
$4.83M
$3.06M
$4.66M
$5.21M
$43.34M
$37.41M
$19.29M
$22.35M
$24.29M
$19.62M
Receivables
$9.21M
$2.43M
$6.38M
$3.21M
$2.59M
$3.21M
$3.62M
—
—
—
Total assets
$2.40B
$2.55B
$2.75B
$3.04B
$3.12B
$2.84B
$2.51B
$2.49B
$2.61B
$2.80B
Long-term debt
$1.13B
—
—
—
—
—
—
—
—
—
Total debt
$1.13B
—
—
—
—
—
—
—
—
—
Total liabilities
$1.19B
$1.22B
$1.36B
$1.54B
$1.60B
$1.32B
$1.22B
$1.21B
$1.23B
$1.26B
Shareholders' equity
$1.21B
$1.32B
$1.39B
$1.50B
$1.51B
$1.51B
$1.27B
$1.25B
$1.37B
$1.52B
Cash flow
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Operating cash flow
$176.64M
$198.09M
$207.87M
$240.96M
$232.15M
$210.86M
$185.34M
$184.45M
$207.77M
$236.56M
Capital expenditures
$394.74M
$175.79M
$147.65M
$237.19M
$116.72M
$50.35M
$10.99M
$49.56M
$157.93M
$294.03M
Free cash flow
-$218.10M
$22.30M
$60.22M
$3.77M
$115.42M
$160.51M
$174.35M
$134.89M
$49.84M
-$57.47M
Investing cash flow
-$329.84M
-$163.85M
-$250.29M
-$342.52M
-$89.71M
$185.28M
$197.94M
-$11.63M
-$192.31M
-$269.15M
Financing cash flow
$144.16M
-$35.05M
$44.26M
$107.32M
-$111.76M
-$402.99M
-$401.25M
-$169.72M
-$13.57M
$25.71M
Dividends paid
$138.30M
$153.04M
$165.39M
$179.74M
$194.58M
$182.90M
$161.77M
$156.24M
$156.51M
$169.70M
Share buybacks
—
—
—
—
$0
$0
$151.95M
$0
$0
—
Stock-based compensation
$1.73M
$2.61M
$2.49M
$3.65M
$5.45M
$5.08M
$8.61M
$4.61M
$4.18M
$5.58M
Depreciation & amortization
$59.52M
$67.17M
$71.35M
$76.82M
$83.15M
$80.80M
$70.88M
$69.97M
$71.44M
$80.94M
Income statement
quarters · USD
Quarter ended
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
$12.37M
$12.95M
$13.26M
$13.39M
$13.77M
$14.01M
$13.94M
$14.22M
$21.18M
$30.73M
$37.06M
$44.78M
Interest expense
$15.09M
$14.85M
$14.87M
$14.85M
$14.94M
$15.24M
$14.34M
$15.00M
$13.77M
$14.26M
$15.04M
$15.81M
Pre-tax income
—
—
—
—
—
—
—
$35.16M
—
—
—
$56.09M
Income tax
—
—
—
—
—
—
—
$0
—
—
—
$732.00K
Net income
$29.35M
$32.05M
$30.95M
$35.26M
$28.54M
$43.24M
$34.16M
$36.99M
$32.86M
$38.16M
$40.10M
$55.67M
EPS (basic)
$0.68
$0.74
$0.71
$0.81
$0.66
$0.96
$0.75
$0.79
$0.69
$0.80
$0.83
$1.15
EPS (diluted)
$0.68
$0.74
$0.71
$0.81
$0.65
$0.96
$0.74
$0.79
$0.69
$0.80
$0.82
$1.15
Diluted shares
43.39M
-209
43.42M
43.56M
43.99M
444.21K
45.88M
46.82M
47.62M
276.89K
48.55M
48.50M
Net margin
237.3%
247.5%
233.5%
263.3%
207.2%
308.8%
245.1%
260.2%
155.2%
124.2%
108.2%
124.3%
Balance sheet
quarters · USD
Quarter ended
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Cash & equivalents
$16.58M
$22.35M
$11.36M
$14.77M
$15.55M
$24.29M
$135.00M
$18.64M
$81.62M
$19.62M
$24.95M
$30.39M
Total assets
$2.50B
$2.49B
$2.48B
$2.48B
$2.46B
$2.61B
$2.78B
$2.70B
$2.69B
$2.80B
$2.89B
$2.96B
Total liabilities
$1.22B
$1.21B
$1.21B
$1.21B
$1.21B
$1.23B
$1.34B
$1.20B
$1.19B
$1.26B
$1.36B
$1.37B
Shareholders' equity
$1.26B
$1.25B
$1.25B
$1.24B
$1.23B
$1.37B
$1.43B
$1.48B
$1.48B
$1.52B
$1.51B
$1.57B
Cash flow
quarters · USD
Quarter ended
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Operating cash flow
$49.70M
$53.20M
$40.83M
$60.74M
$48.63M
$57.57M
$46.48M
$59.82M
$62.53M
$67.74M
$53.44M
$64.97M
Capital expenditures
—
—
—
—
—
$133.12M
$85.17M
—
—
$196.29M
$109.42M
—
Free cash flow
$49.70M
$53.20M
$40.83M
$60.74M
$48.63M
-$75.54M
-$38.69M
$59.82M
$62.53M
-$128.56M
-$55.98M
$64.97M
Investing cash flow
-$19.95M
$2.34M
-$16.19M
-$13.35M
-$1.57M
-$161.20M
-$75.47M
-$48.32M
$41.67M
-$187.03M
-$103.89M
-$43.41M
Financing cash flow
-$30.54M
-$49.42M
-$35.92M
-$43.81M
-$46.19M
$112.36M
$139.77M
-$129.46M
-$41.90M
$57.29M
$55.77M
$3.93M
Dividends paid
$39.07M
$39.07M
$39.07M
$39.08M
$39.10M
$39.26M
$41.12M
$42.02M
$42.73M
$43.83M
$44.44M
$44.58M
Share buybacks
$0
$0
—
—
—
—
—
—
—
—
—
—
Stock-based compensation
$866.00K
$865.00K
$2.15M
$687.00K
$670.00K
$670.00K
$2.56M
$1.07M
$983.00K
$964.00K
$2.24M
$2.36M
Depreciation & amortization
$17.52M
$17.11M
$17.50M
$17.49M
$17.77M
$18.68M
$19.16M
$19.92M
$20.22M
—
$23.69M
$25.55M
Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.